Sonendo, Inc. (SONX)

USD 2.19

(6.31%)

Operating Expenses Summary of Sonendo, Inc.

  • Sonendo, Inc.'s latest annual operating expenses in 2023 was 68.46 Million USD , down -3.36% from previous year.
  • Sonendo, Inc.'s latest quarterly operating expenses in 2024 Q2 was 9.8 Million USD , down -19.98% from previous quarter.
  • Sonendo, Inc. reported a annual operating expenses of 68.68 Million USD in annual operating expenses 2022, up 30.87% from previous year.
  • Sonendo, Inc. reported a annual operating expenses of 52.48 Million USD in annual operating expenses 2021, up 11.29% from previous year.
  • Sonendo, Inc. reported a quarterly operating expenses of 9.8 Million USD for 2024 Q2, down -19.98% from previous quarter.
  • Sonendo, Inc. reported a quarterly operating expenses of 18.16 Million USD for 2023 Q1, up 0.37% from previous quarter.

Annual Operating Expenses Chart of Sonendo, Inc. (2023 - 2019)

Historical Annual Operating Expenses of Sonendo, Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 68.46 Million USD -3.36%
2022 68.68 Million USD 30.87%
2021 52.48 Million USD 11.29%
2020 47.15 Million USD -13.52%
2019 54.52 Million USD 0.0%

Peer Operating Expenses Comparison of Sonendo, Inc.

Name Operating Expenses Operating Expenses Difference
Abbott Laboratories 15.71 Billion USD 99.564%
Allurion Technologies Inc. 120.57 Million USD 43.218%
Artivion, Inc. 223.43 Million USD 69.358%
Avanos Medical, Inc. 375.5 Million USD 81.767%
Butterfly Network, Inc. 162.46 Million USD 57.859%
Butterfly Network, Inc. 162.46 Million USD 57.859%
Bio-Rad Laboratories, Inc. 1.04 Billion USD 93.464%
Boston Scientific Corporation 7.47 Billion USD 99.084%
Perspective Therapeutics, Inc. 17.42 Million USD -292.89%
CONMED Corporation 564.24 Million USD 87.866%
Edwards Lifesciences Corporation 3.09 Billion USD 97.785%
Paragon 28, Inc. 210.1 Million USD 67.413%
Glaukos Corporation 367.83 Million USD 81.387%
Globus Medical, Inc. 887.16 Million USD 92.283%
Inspire Medical Systems, Inc. 568.49 Million USD 87.957%
Integer Holdings Corporation 250.95 Million USD 72.719%
Medtronic plc 16.12 Billion USD 99.576%
Nevro Corp. 389.36 Million USD 82.416%
Owlet, Inc. 51.21 Million USD -33.671%
Penumbra, Inc. 590.87 Million USD 88.413%
Vicarious Surgical Inc. 80.66 Million USD 15.125%
Smith & Nephew plc 3.46 Billion USD 98.025%
STERIS plc 1.4 Billion USD 95.111%
Stryker Corporation 9.2 Billion USD 99.257%
Vapotherm, Inc. 66.02 Million USD -3.696%
Zimmer Biomet Holdings, Inc. 3.27 Billion USD 97.91%